Good 4c on the expense side. I think funding concerns should be relaxed given the current burn rate which is a big plus. Market should like this and SP should climb to around 15 IMO. Any boost in revenue (e.g. from the UK) will rerate SP much higher. Don't think there is room for another update. They should focus on execution
- Forums
- ASX - By Stock
- GMV
- Ann: Appendix 4C - quarterly
Ann: Appendix 4C - quarterly, page-19
-
- There are more pages in this discussion • 95 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online